OGVHD
Clinical trials for OGVHD explained in plain language.
Never miss a new study
Get alerted when new OGVHD trials appear
Sign up with your email to follow new studies for OGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chronic eye GVHD: expanded access to d-MAPPS eye drops
Disease control AVAILABLEThis program provides early access to an investigational eye drop called d-MAPPS for people suffering from chronic ocular Graft-Versus-Host Disease (oGVHD), a painful eye condition that can occur after a stem cell or bone marrow transplant. It is for adults aged 18 and older who …
Matched conditions: OGVHD
Sponsor: Regenerative Ocular Immunobiologics LLC • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New biobank study aims to unlock secrets of eye disease in cancer survivors
Knowledge-focused Recruiting nowThis study looks at why some cancer patients develop severe dry eye after a stem cell transplant (called ocular graft-versus-host disease). Researchers will collect eye samples from 150 adults to find new treatment targets and early warning signs. The goal is to better understand…
Matched conditions: OGVHD
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated May 17, 2026 08:17 UTC